BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12695813)

  • 1. Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer.
    Ricke J; Sehouli J; Hach C; Hänninen EL; Lichtenegger W; Felix R
    Eur Radiol; 2003 May; 13(5):943-9. PubMed ID: 12695813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer.
    Sanli Y; Turkmen C; Bakir B; Iyibozkurt C; Ozel S; Has D; Yilmaz E; Topuz S; Yavuz E; Unal SN; Mudun A
    Nucl Med Commun; 2012 May; 33(5):509-15. PubMed ID: 22357440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent ovarian malignancy: patterns and spectrum of imaging findings.
    Park CM; Kim SH; Kim SH; Moon MH; Kim KW; Choi HJ
    Abdom Imaging; 2003; 28(3):404-15. PubMed ID: 12719914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT.
    Low RN; Carter WD; Saleh F; Sigeti JS
    Radiology; 1995 May; 195(2):391-400. PubMed ID: 7724757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study.
    Testa AC; Ludovisi M; Mascilini F; Di Legge A; Malaggese M; Fagotti A; Fanfani F; Salerno MG; Ercoli A; Scambia G; Ferrandina G
    Ultrasound Obstet Gynecol; 2012 Jan; 39(1):99-105. PubMed ID: 21913276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
    Kim CK; Park BK; Choi JY; Kim BG; Han H
    J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative staging of ovarian cancer: comparison between ultrasound, CT and whole-body diffusion-weighted MRI (ISAAC study).
    Fischerova D; Pinto P; Burgetova A; Masek M; Slama J; Kocian R; Frühauf F; Zikan M; Dusek L; Dundr P; Cibula D
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):248-262. PubMed ID: 33871110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abdominal recurrence of ovarian cancer: value of abdominal MR in patients with positive CA125 and negative CT.
    Balestreri L; Bison L; Sorio R; Morra A; Campagnutta E; Morassut S
    Radiol Med; 2002; 104(5-6):426-36. PubMed ID: 12589264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma.
    Kubik-Huch RA; Dörffler W; von Schulthess GK; Marincek B; Köchli OR; Seifert B; Haller U; Steinert HC
    Eur Radiol; 2000; 10(5):761-7. PubMed ID: 10823629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentric trial (Olympia-MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer.
    Fagotti A; Vizzielli G; De Iaco P; Surico D; Buda A; Mandato VD; Petruzzelli F; Ghezzi F; Garzarelli S; Mereu L; Viganò R; Tateo S; Fanfani F; Scambia G
    Am J Obstet Gynecol; 2013 Nov; 209(5):462.e1-462.e11. PubMed ID: 23891632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary ovarian cancer: prospective comparison of contrast-enhanced CT and pre-and postcontrast, fat-suppressed MR imaging, with histologic correlation.
    Semelka RC; Lawrence PH; Shoenut JP; Heywood M; Kroeker MA; Lotocki R
    J Magn Reson Imaging; 1993; 3(1):99-106. PubMed ID: 8428108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrahepatic abdominal imaging in patients with malignancy: comparison of MR imaging and helical CT, with subsequent surgical correlation.
    Low RN; Semelka RC; Worawattanakul S; Alzate GD; Sigeti JS
    Radiology; 1999 Mar; 210(3):625-32. PubMed ID: 10207459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: preliminary results.
    Keller TM; Michel SC; Fröhlich J; Fink D; Caduff R; Marincek B; Kubik-Huch RA
    Eur Radiol; 2004 Jun; 14(6):937-44. PubMed ID: 14991323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign and malignant gynecologic disease: clinical importance of fluid and peritoneal enhancement in the pelvis at MR imaging.
    Outwater EK; Siegelman ES; Wilson KM; Mitchell DG
    Radiology; 1996 Aug; 200(2):483-8. PubMed ID: 8685345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings--a feasibility study.
    Low RN; Sebrechts CP; Barone RM; Muller W
    AJR Am J Roentgenol; 2009 Aug; 193(2):461-70. PubMed ID: 19620444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
    Low RN; Sigeti JS
    AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer recurrence: value of MR imaging.
    Forstner R; Hricak H; Powell CB; Azizi L; Frankel SB; Stern JL
    Radiology; 1995 Sep; 196(3):715-20. PubMed ID: 7644634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer: staging with CT and MR imaging.
    Forstner R; Hricak H; Occhipinti KA; Powell CB; Frankel SD; Stern JL
    Radiology; 1995 Dec; 197(3):619-26. PubMed ID: 7480729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
    Grueneisen J; Beiderwellen K; Heusch P; Gratz M; Schulze-Hagen A; Heubner M; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L
    Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
    Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
    AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.